• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[塞内加尔氯喹耐药疟疾的异质性]

[Heterogeneity of chloroquine resistant malaria in Senegal].

作者信息

Gaye O, Soumaré M, Sambou B, Faye O, Dieng Y, Diouf M, Bah I B, Dieng T, N'dir O, Diallo S

机构信息

Service de parasitologie, Faculté de médecine, UCAD, Dakar, Sénégal.

出版信息

Bull Soc Pathol Exot. 1999 Jul;92(3):149-52.

PMID:10472437
Abstract

In order to evaluate the in vivo efficacy of chloroquine in the treatment of P. falciparum malaria, studies have been carried out in Richard-Toll, Fatick and Tambacounda, 3 areas where dynamics of transmission, population movements, as well as prophylactic and curative practises are different. Failure rates in treatment were 13% in site 1 (Richard-Toll) where medical pressure and population movements are high. In sites 2 and 3 (Fatick and Tambacounda), the failure rate was 3%. Even if medical pressure is lower in the latter site (Tambacounda), the higher transmission could be a factor in the spreading of resistance. A surveillance system and better use of chloroquine must be undertaken.

摘要

为了评估氯喹治疗恶性疟原虫疟疾的体内疗效,已在理查德 - 托尔、法蒂克和坦巴昆达开展了研究,这三个地区的传播动态、人口流动以及预防和治疗措施各不相同。在医疗压力和人口流动较大的1号地点(理查德 - 托尔),治疗失败率为13%。在2号和3号地点(法蒂克和坦巴昆达),失败率为3%。即使后一个地点(坦巴昆达)的医疗压力较低,但较高的传播率可能是耐药性传播的一个因素。必须建立监测系统并更好地使用氯喹。

相似文献

1
[Heterogeneity of chloroquine resistant malaria in Senegal].[塞内加尔氯喹耐药疟疾的异质性]
Bull Soc Pathol Exot. 1999 Jul;92(3):149-52.
2
[Impact of antimalarial drug accessibility on malarial morbidity and chloroquine resistance. A study carried out in Touba (Senegal)].[抗疟药物可及性对疟疾发病率和氯喹耐药性的影响。在图巴(塞内加尔)开展的一项研究]
Bull Soc Pathol Exot. 1997;90(5):318-20.
3
New trends in chloroquine efficacy in the treatment of malaria: chloroquine-resistant Plasmodium falciparum in Anambra and Benue States of Nigeria.
Cent Afr J Med. 1991 Jun;37(6):180-6.
4
Assessment of therapeutic efficacy of chloroquine against falciparum malaria in an outbreak area in Xishuangbanna, Yunnan.云南西双版纳某疟疾暴发区氯喹治疗恶性疟疗效评估
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2002;20(2):94-7.
5
[Chloroquine resistant strains of Plasmodium falciparum in the Anopheles vector and use of antimalarials].[按蚊载体中恶性疟原虫的氯喹抗性菌株及抗疟药的使用]
Dakar Med. 1996;Spec No:7-9.
6
Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.氯喹(CQ)和周效磺胺/乙胺嘧啶(SP)治疗印缅边境地区非复杂性恶性疟的疗效评估。
Trop Med Int Health. 2005 May;10(5):478-83. doi: 10.1111/j.1365-3156.2005.01401.x.
7
Therapeutic efficacy of chloroquine against uncomplicated, Plasmodium falciparum malaria in south-western Saudi Arabia.氯喹对沙特阿拉伯西南部非复杂性恶性疟原虫疟疾的治疗效果。
Ann Trop Med Parasitol. 2001 Dec;95(8):773-9. doi: 10.1080/0003498012011127.
8
[Drug resistance of Plasmodium falciparum in coastal regions of Madagascar].
Med Trop (Mars). 2000;60(3):243-9.
9
Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.氯喹或阿莫地喹联合磺胺多辛-乙胺嘧啶治疗巴布亚新几内亚非复杂性恶性疟的疗效
P N G Med J. 2003 Sep-Dec;46(3-4):125-34.
10
Chloroquine-resistant Plasmodium falciparum malaria in Ilorin, Nigeria: prevalence and risk factors for treatment failure.尼日利亚伊洛林地区耐氯喹恶性疟原虫疟疾:治疗失败的患病率及危险因素
Afr J Med Med Sci. 2001 Sep;30(3):165-9.

引用本文的文献

1
Country-Wide Surveillance of Molecular Markers of Antimalarial Drug Resistance in Senegal by Use of Positive Malaria Rapid Diagnostic Tests.通过使用疟疾快速诊断检测阳性结果对塞内加尔抗疟药物耐药性分子标志物进行全国范围监测
Am J Trop Med Hyg. 2017 Nov;97(5):1593-1596. doi: 10.4269/ajtmh.17-0021.
2
Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.塞内加尔停用氯喹数年之后对恶性疟原虫氯喹耐药性的分子标志物(PfCRT)的评估。
Am J Trop Med Hyg. 2012 Oct;87(4):640-645. doi: 10.4269/ajtmh.2012.11-0709. Epub 2012 Aug 27.
3
Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).
1992年至2004年塞内加尔尼亚喀出现氯喹耐药性后,三家医疗机构的抗疟药物处方情况。
Malar J. 2009 Apr 27;8:83. doi: 10.1186/1475-2875-8-83.
4
Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.在塞内加尔皮金地区,疟原虫氯喹抗性转运蛋白(PFCRT)K76T位点的突变与周效磺胺-乙胺嘧啶-阿莫地喹治疗失败无关。
Parasitol Res. 2008 Sep;103(4):765-9. doi: 10.1007/s00436-008-1038-9. Epub 2008 Jun 5.
5
Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in Senegal.塞内加尔恶性疟原虫pfcrt基因多态性的流行情况及体外氯喹敏感性
Parasitology. 2003 May;126(Pt 5):401-5. doi: 10.1017/s0031182003002981.